home / stock / nvcn / nvcn quote
Last: | $30.03 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $30.03 |
High: | $0 |
Low: | $0 |
Volume: | 2 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$30.03 | $0 | $30.03 | $0 | $0 | 2 | 04-11-2023 |
$30.03 | $29.59 | $30.03 | $30.07 | $29.43 | 45,477 | 04-10-2023 |
$29.54 | $29.66 | $29.54 | $29.75 | $29.54 | 6,356 | 04-07-2023 |
$29.54 | $29.66 | $29.54 | $29.75 | $29.54 | 6,356 | 04-06-2023 |
$29.75 | $29.75 | $29.75 | $29.95 | $29.09 | 41,616 | 04-05-2023 |
$29.67 | $29.68 | $29.67 | $29.82 | $29.5 | 6,367 | 04-04-2023 |
$29.75 | $29.1 | $29.75 | $29.9 | $29.1 | 26,050 | 04-03-2023 |
$29.15 | $29.15 | $29.15 | $29.25 | $29.1 | 13,498 | 03-31-2023 |
$29.16 | $29.1 | $29.16 | $29.25 | $29.05 | 11,950 | 03-30-2023 |
$29.1 | $29.18 | $29.1 | $29.36 | $29.05 | 21,585 | 03-29-2023 |
$29.17 | $29.34 | $29.17 | $29.7 | $29.06 | 28,664 | 03-28-2023 |
$29.49 | $29.44 | $29.49 | $29.73 | $29.41 | 27,674 | 03-27-2023 |
$29.88 | $29.41 | $29.88 | $29.89 | $29.4 | 46,864 | 03-24-2023 |
$29.42 | $29.68 | $29.42 | $29.68 | $29.42 | 9,120 | 03-23-2023 |
$29.71 | $29.28 | $29.71 | $29.75 | $29.28 | 28,045 | 03-22-2023 |
$29.36 | $29.38 | $29.36 | $29.54 | $29.29 | 30,479 | 03-21-2023 |
$29.26 | $29.2 | $29.26 | $29.3699 | $29.2 | 18,603 | 03-20-2023 |
$29.34 | $29.1 | $29.34 | $29.585 | $29.1 | 40,830 | 03-17-2023 |
$29.34 | $29.31 | $29.34 | $29.45 | $29.04 | 45,393 | 03-16-2023 |
$29.5 | $29.25 | $29.5 | $29.5 | $29.1001 | 40,931 | 03-15-2023 |
News, Short Squeeze, Breakout and More Instantly...
Neovasc Inc. (NASDAQ: NVCN) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.48% on the day to $29.23. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. It...
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Hi...
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as d...